Case number 1:18-cv-00555
IBSA Institut Biochimique, S.A. et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 19, 2022 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [112] Notice of Appeal (Federal Circuit). (mal) |
| Oct 9, 2020 | 119 | Main Document (1) Docket Text: MANDATE of USCA as to [112] Notice of Appeal (Federal Circuit), filed by IBSA Pharma Inc., IBSA Institut Biochimique, S.A., Altergon, S.A.. USCA Decision: Affirmed. (Attachments: # (1) Opinion, # (2) Judgment)(nms) |
| Oct 9, 2020 | 119 | Opinion (13) |
| Oct 9, 2020 | 119 | Judgment (1) |
| Oct 2, 2020 | 118 | USCA Order (2) Docket Text: ORDER of USCA as to [112] Notice of Appeal (Federal Circuit), filed by IBSA Pharma Inc., IBSA Institut Biochimique, S.A., Altergon, S.A.. Decision of USCA for the Federal Circuit: The petition for panel rehearing is denied. The petition for rehearing en banc is denied. The mandate of the court will issue on October 9, 2020. (nms) |
| Jun 20, 2020 | 56 | Motion to Dismiss (3) |
| Jun 20, 2020 | N/A | Set Answering Brief Deadline (0) |
| Sep 23, 2019 | 117 | Redacted Document (3) Docket Text: REDACTED VERSION of [115] Stipulation by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) |
| Sep 16, 2019 | 114 | USCA Notice of Docketing ROA (1) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [112] Notice of Appeal (Federal Circuit),filed by IBSA Pharma Inc., IBSA Institut Biochimique, S.A., Altergon, S.A.. USCA Case Number 19-2400. (nms) |
| Sep 12, 2019 | 113 | Patent/Trademark Report to Commissioner (1) |
| Sep 12, 2019 | 113 | Order and Final Judgment (3) |
| Sep 12, 2019 | 113 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,691,411 B2; 7,723,390 B2. (Attachments: # (1) Order and Final Judgment)(nms) |
| Sep 10, 2019 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [112] Notice of Appeal (Federal Circuit) filed by IBSA Pharma Inc., IBSA Institut Biochimique, S.A., Altergon, S.A.. ( Filing fee $505, receipt number 0311-2727111.) (Egan, Brian) |
| Sep 10, 2019 | N/A | Appeal Notification to Reporter Triozzi (0) Docket Text: Notification regarding [112] Notice of Appeal (Federal Circuit) sent to Reporter Triozzi (mal) |
| Sep 10, 2019 | 111 | Order (3) Docket Text: CLAIM CONSTRUCTION ORDER AND FINAL JUDGMENT (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/9/2019. (nms) |
| Sep 10, 2019 | 112 | Notice of Appeal (Federal Circuit) (3) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [111] Order, Terminated Case, [107] Memorandum Opinion, . Appeal filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) |
| Sep 10, 2019 | 112 | Notice of Appeal* (1) |
| Sep 6, 2019 | 110 | Proposed Order (3) Docket Text: PROPOSED Claim Construction Order and Final Judgment, by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) Modified on 9/9/2019 (nms). |
| Aug 30, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [109] Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 8/30/2019. (nms) |
| Aug 30, 2019 | 109 | Stipulation (2) Docket Text: STIPULATION and Proposed Order, by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) Modified on 8/30/2019 (nms). |
| Aug 27, 2019 | N/A | SO ORDERED (0) |
| Aug 26, 2019 | 108 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed order consistent with the Court's August 20, 2019 Memorandum Opinion (D.I. 107) to August 30, 2019 - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) |
| Aug 20, 2019 | 107 | Memorandum Opinion (19) Docket Text: MEMORANDUM OPINION providing claim construction for multiple terms in U.S. Patent No. 7,723,390. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 8/16/2019. (nms) |
| Aug 14, 2019 | N/A | SO ORDERED (0) |
| Aug 13, 2019 | 106 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of Expert Report Deadlines to Various Dates - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) |
| Jul 31, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Byron L. Pickard and Matthew M. Zuziak for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jul 29, 2019 | N/A | SO ORDERED (0) |
| Jul 29, 2019 | 105 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney So Yeon Choe - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) |
| Jul 26, 2019 | 104 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Notice of Deposition of Giuseppe Mautone Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 25, 2019 | N/A | SO ORDERED (0) |
| Jul 24, 2019 | 103 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Byron L. Pickard and Matthew M. Zuziak - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jul 23, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The motion filed at D.I. 103 has been removed from the docket as the caption contained an error (initials after case number). Counsel shall refile the motion correcting the error. (nms) |
| Jul 22, 2019 | N/A | SO ORDERED (0) |
| Jul 19, 2019 | 100 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's Supplemental Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 19, 2019 | 101 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Teva's Second Set of Interrogatories (Nos. 9-24) to Plaintiffs; (2) Plaintiffs' First Supplemental Responses and Objections to Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Interrogatories (Nos. 1, 2, 4, 6); and (3) Plaintiffs' Responses and Objections to Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Requests for Admission (Nos. 1-50), filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jul 19, 2019 | 102 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Chandrika Vira and Matthew Mahoney - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jul 12, 2019 | 99 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Notice of Deposition of Aldo Donati Pursuant to Federal Rule of Civil Procedure 30(b)(1) (2) Defendant's Notice of Deposition of Rosita Selva Pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 11, 2019 | 97 | Letter (4) |
| Jul 11, 2019 | 97 | Exhibit A (18) |
| Jul 11, 2019 | 97 | Exhibit B (21) |
| Jul 11, 2019 | 98 | Letter (7) Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding claim construction of the term "half-liquid". (Blumenfeld, Jack) |
| Jul 11, 2019 | 97 | Main Document (4) Docket Text: Letter to The Honorable Richard Andrews from Nathan R. Hoeschen. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Hoeschen, Nathan) |
| Jul 10, 2019 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[90]. (nms) |
| Jul 10, 2019 | 96 | Redacted Document (6) Docket Text: REDACTED VERSION of [90] Notice of Lodging Dr. Chyalls Claim Construction Deposition, by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 7/11/2019 (nms). |
| Jul 5, 2019 | 95 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Responses and Objections to Defendant Teva Pharmaceuticals Inc.'s Notice to Take the Deposition of IBSA Pharma Inc. pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Responses and Objections to Defendant Teva Pharmaceuticals Inc.'s Notices to Take the Depositions of IBSA Institut Biochimique, S.A. and Altergon, S.A. pursuant to Fed. R. Civ. P. 30(b)(6) filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jul 2, 2019 | 94 | Transcript (110) Docket Text: Official Transcript of Markman Hearing held on 06/27/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/23/2019. Redacted Transcript Deadline set for 8/2/2019. Release of Transcript Restriction set for 9/30/2019. (Triozzi, Heather) |
| Jul 1, 2019 | 93 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiff's Notice of Deposition of Teva Pharmaceuticals USA, Inc. pursuant to Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 28, 2019 | N/A | Redaction Notice (0) |
| Jun 28, 2019 | 92 | Redacted Document (30) Docket Text: REDACTED VERSION of [80] Notice of Lodging Dr. Chyalls Claim Construction Deposition Transcript, by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 6/28/2019 (nms). |
| Jun 27, 2019 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 6/27/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendant: N. Hoeschen. (Court Reporter Heather Triozzi.) (crb) |
| Jun 27, 2019 | 91 | Redacted Document (30) Docket Text: REDACTED VERSION of [86] Notice of Lodging of Claim Construction Deposition Transcripts, by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) Modified on 6/27/2019 (nms). |
| Jun 26, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing scheduled for 6/27/2019, will now be held in Courtroom 6C. Ordered by Judge Richard G. Andrews on 6/26/2019. (nms) |
| Jun 26, 2019 | 89 | Redacted Document (17) Docket Text: REDACTED VERSION of [84] Notice of Subpoenas, by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Egan, Brian) Modified on 6/26/2019 (nms). |
| Jun 21, 2019 | 87 | Redacted Document (6) Docket Text: REDACTED VERSION of [74] Notice to Take Deposition by Altergon, S.A., IBSA Institut Biochimique, S.A.. (Egan, Brian) |
| Jun 19, 2019 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Notice of Deposition of Alberto Garavani pursuant to Federal Rule of Civil Procedure 30(b)(1) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 19, 2019 | 83 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Craig Jones on July 3, 2019 filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jun 19, 2019 | 85 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's First Set of Requests for Admissions (Nos. 1-50) to Plaintiffs, Teva's Second Set of Interrogatories (Nos. 9-24) to Plaintiffs filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 18, 2019 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1)Defendants Notice of Deposition of Angel Mateo Enchanagorria pursuant to Federal Rule of Civil Procedure 30(b)(1) 2)Defendants Notice of Deposition of Maurizio Marchiorro pursuant to Federal Rule of Civil Procedure 30(b)(1) 3)Defendants Notice of Deposition of Alessandro Di Martino pursuant to Federal Rule of Civil Procedure 30(b)(1) 4)Defendants Notice of Deposition of Claudia Scarsi pursuant to Federal Rule of Civil Procedure 30(b)(1) 5)Defendants Notice of Deposition of Tiziano Fossati pursuant to Federal Rule of Civil Procedure 30(b)(1) 6)Defendants Notice of Deposition of IBSA Institut Biochimique, S.A. pursuant to Fed. R. Civ. P. 30(b)(6) 7)Defendants Notice of Deposition of IBSA Pharma Inc. pursuant to Fed. R. Civ. P. 30(b)(6) 8)Defendants Notice of Deposition of Altergon, S.A. pursuant to Fed. R. Civ. P. 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 14, 2019 | 75 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Gerarde Sweeney on July 1, 2019 filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jun 14, 2019 | 76 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of James Mills on July 1, 2019 filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jun 14, 2019 | 77 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Renata Degady on July 1, 2019 filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jun 14, 2019 | 78 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Simmer Verma on July 1, 2019 filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Jun 14, 2019 | 79 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Amended Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' First Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| May 30, 2019 | N/A | Oral Order (0) |
| May 29, 2019 | N/A | Redaction Notice (0) |
| May 29, 2019 | 72 | Redacted Document (3) |
| May 29, 2019 | 72 | Exhibits A-HH (492) |
| May 29, 2019 | 72 | Main Document (3) Docket Text: REDACTED VERSION of [71] Appendix by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc.. (Attachments: # (1) Exhibits A-HH)(Egan, Brian) |
| May 17, 2019 | 70 | Claim Construction Opening Brief (30) Docket Text: Joint Claim Construction Brief, filed by Altergon, S.A., IBSA Institut Biochimique, S.A.. (Egan, Brian) Modified on 5/17/2019 (nms). |
| May 9, 2019 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents, ESI, and Things (Nos. 79-83) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Apr 24, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 24, 2019 | 68 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Altergon, S.A., IBSA Institut Biochimique, S.A., IBSA Pharma Inc..(Egan, Brian) |
| Apr 22, 2019 | N/A | Oral Order (0) |
| Apr 22, 2019 | 66 | Redacted Document (4) Docket Text: REDACTED VERSION of [63] Sur-Sur Reply, by Altergon, S.A., IBSA Institut Biochimique, S.A.. (Egan, Brian) Modified on 4/23/2019 (nms). |
| Apr 22, 2019 | 67 | Redacted Document (2) |
| Apr 22, 2019 | 67 | Exhibit A (2) |
| Apr 22, 2019 | 67 | Main Document (2) Docket Text: REDACTED VERSION of [64] Declaration by Altergon, S.A., IBSA Institut Biochimique, S.A.. (Attachments: # (1) Exhibit A)(Egan, Brian) |
| Apr 9, 2019 | 62 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents, ESI and Things (Nos. 79-83) filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Egan, Brian) |
| Apr 8, 2019 | N/A | Oral Order (0) |
| Apr 4, 2019 | N/A | SO ORDERED (0) |
| Apr 4, 2019 | N/A | SO ORDERED (0) |
| Apr 4, 2019 | 59 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Laura Moran - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Egan, Brian) |
| Apr 4, 2019 | 60 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to May 1, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 29, 2019 | 58 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Responses and Objections of IBSA Institut Biochimique, SA., Altergon, S.A., Mist Acquisition, LLC and Mist Pharmaceuticals, LLC to Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-116); and (2) Plaintiffs' Responses and Objections to Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Interrogatories (Nos. 1-8), filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Egan, Brian) |
| Mar 19, 2019 | 57 | Order (1) Docket Text: ORDER Granting [56] Joint MOTION for Partial Dismissal Without Prejudice Pursuant to Rule 41(a)(2). Signed by Judge Richard G. Andrews on 3/19/2019. (nms) |
| Mar 18, 2019 | 55 | Redacted Document (6) Docket Text: REDACTED VERSION of [54] Sur-Reply Brief by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 18, 2019 | 56 | Exhibit A (2) |
| Mar 18, 2019 | 56 | Main Document (3) Docket Text: Joint MOTION to Dismiss Based upon Partial Dismissal Without Prejudice Pursuant to Rule 41(a)(2) - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A)(Egan, Brian) |
| Mar 15, 2019 | 53 | Order (1) Docket Text: ORDER Granting [49] MOTION for Leave to File a Sur-Reply. Signed by Judge Richard G. Andrews on 3/15/2019. (nms) |
| Mar 6, 2019 | 51 | Redacted Document (13) Docket Text: REDACTED VERSION of [49] MOTION for Leave to File a Sur-Reply to Motion to Substitute IBSA Pharma Inc. for Mist Acquisition, LLC, and Mist Pharmaceuticals, LLC, and to Change the Caption by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 6, 2019 | 52 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Construction Opening Brief filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Egan, Brian) |
| Feb 27, 2019 | N/A | Set Answering Brief Deadline (0) Docket Text: Set Answering Brief Deadline re [49] MOTION for Leave to File a Sur-Reply to Motion to Substitute IBSA Pharma Inc. for Mist Acquisition, LLC, and Mist Pharmaceuticals, LLC, and to Change the Caption. Answering Brief/Response due date per Local Rules is 3/13/2019. (nms) |
| Feb 27, 2019 | 50 | Redacted Document (7) Docket Text: REDACTED VERSION of [46] Reply Brief, by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Egan, Brian) |
| Feb 22, 2019 | 47 | Redacted Document (16) Docket Text: REDACTED VERSION of [44] Response to Motion by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Feb 22, 2019 | 48 | Redacted Document (30) Docket Text: REDACTED VERSION of [45] Declaration,, by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Feb 12, 2019 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Teva's First Set of Interrogatories (Nos. 1-8) to Plaintiffs and 2) Teva's First Set of Requests for the Production of Documents and Things (Nos. 1-116) to Plaintiffs filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Feb 8, 2019 | 42 | Claim Construction Chart (10) |
| Feb 8, 2019 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Supplemental Response to Plaintiffs' First Set of Interrogatories (No. 4) filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Feb 8, 2019 | 42 | Exhibits A-O (203) |
| Feb 8, 2019 | 42 | Exhibits AA-HH (107) |
| Feb 8, 2019 | 42 | Main Document (10) Docket Text: Joint Claim Construction Chart, by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Attachments: # (1) Exhibits A-O, # (2) Exhibits AA-HH)(Egan, Brian) Modified on 2/11/2019 (nms). |
| Jan 31, 2019 | N/A | SO ORDERED (0) |
| Jan 30, 2019 | 40 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to respond to Plaintiffs' Motion to Substitute IBSA Pharma Inc. in Place of Mist Acquisition, LLC and Mist Pharmaceuticals, LLC and to Change the Caption (D.I. 35) to February 13, 2019 - filed by Teva Pharmaceuticals USA, Inc.. (Fry, David) |
| Jan 23, 2019 | 38 | Redacted Document (7) |
| Jan 23, 2019 | 39 | Redacted Document (3) |
| Jan 23, 2019 | 38 | Exhibit 1 (2) |
| Jan 23, 2019 | 39 | Exhibits A-D (8) |
| Jan 23, 2019 | 38 | Main Document (7) Docket Text: REDACTED VERSION of [35] MOTION to Substitute IBSA Pharma Inc. to Replace Mist Acquisition, LLC and Mist Pharmaceuticals, LLC, by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Attachments: # (1) Exhibit 1)(Egan, Brian) Modified on 1/24/2019 (nms). |
| Jan 23, 2019 | 39 | Main Document (3) Docket Text: REDACTED VERSION of [36] Declaration of Eric M. Majchrzak, by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Attachments: # (1) Exhibits A-D)(Egan, Brian) Modified on 1/24/2019 (nms). |
| Jan 22, 2019 | 37 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Disclosures Under Paragraph 4(c) of the District of Delaware Default Standard filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Egan, Brian) |
| Jan 3, 2019 | N/A | SO ORDERED (0) |
| Jan 3, 2019 | 34 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to join other parties and/or to amend pleadings to January 16, 2019 - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Egan, Brian) |
| Dec 14, 2018 | 32 | Proposed Order (7) |
| Dec 14, 2018 | 32 | Letter (1) |
| Dec 14, 2018 | 33 | Order (7) Docket Text: AMENDED SCHEDULING ORDER: Amended Pleadings due by 1/4/2019; Joint Claim Construction Brief due by 5/17/2019; Discovery due by 7/19/2019; Joinder of Parties due by 1/4/2019; A 3 day Bench Trial is set to start 3/9/2020, at 9:30 AM in Courtroom 6A; A Markman Hearing is set for 6/3/2019, at 9:00 AM in Courtroom 6A; A Pretrial Conference is set for 2/28/2020, at 9:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 12/14/2018. (nms) |
| Dec 14, 2018 | 32 | Main Document (7) Docket Text: PROPOSED Amended Scheduling Order, by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Attachments: # (1) Letter)(Egan, Brian) Modified on 12/14/2018 (nms). |
| Dec 13, 2018 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents, ESI, and Things (Nos. 1-78); and 2) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-8) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 5, 2018 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva's Preliminary Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Nov 29, 2018 | N/A | Oral Order (0) |
| Nov 16, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Nov 13, 2018 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs First Set of Interrogatories (Nos. 1-8); 2) Plaintiffs First Set of Requests for Production of Documents, ESI, and Things (Nos. 1-78) filed by IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Egan, Brian) |
| Nov 9, 2018 | N/A | SO ORDERED (0) |
| Nov 8, 2018 | 27 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Erica R. Sutter - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Egan, Brian) |
| Nov 5, 2018 | 26 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Under Paragraph 4(c) of the District of Delaware Default Standard filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Egan, Brian) |
| Sep 18, 2018 | N/A | SO ORDERED (0) |
| Sep 10, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 7, 2018 | 25 | Proposed Order (26) Docket Text: PROPOSED Protective Order, by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Blumenfeld, Jack) Modified on 11/28/2018 (nms). |
| Sep 6, 2018 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 5, 2018 | N/A | SO ORDERED (0) |
| Sep 5, 2018 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard and (2) Plaintiffs' Disclosures Under Paragraph 4(A) of the District of Delaware Default Standard, filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Blumenfeld, Jack) |
| Aug 31, 2018 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint proposed protective order to September 7, 2018 - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Blumenfeld, Jack) |
| Aug 29, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Aug 28, 2018 | 21 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set for 9/17/2018 at 10:45 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 8/28/2018. (dlb) |
| Aug 20, 2018 | N/A | SO ORDERED (0) |
| Aug 16, 2018 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint proposed protective order to August 31, 2018 - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Blumenfeld, Jack) |
| Aug 13, 2018 | 18 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Rule 26 Initial Disclosures filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Aug 13, 2018 | 19 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Blumenfeld, Jack) |
| Aug 6, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (dlb) |
| Aug 6, 2018 | 17 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 7/19/2019. Status Report due by 2/8/2019. Claim Construction Opening Brief due by 4/12/2019. Claim Construction Answering Brief due by 5/10/2019. A Markman Hearing is set for 6/3/2019 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 2/18/2020. A Final Pretrial Conference is set for 2/28/2020 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 7-day Bench Trial is set for 3/9/2020 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 8/2/18. (ntl) |
| Aug 1, 2018 | N/A | SO ORDERED (0) |
| Jul 31, 2018 | 16 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ryan P. Johnson - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Noreika, Maryellen) |
| Jul 18, 2018 | N/A | SO ORDERED (0) |
| Jul 17, 2018 | 14 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke and Eric M. Majchrzak - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Noreika, Maryellen) |
| Jul 17, 2018 | 15 | Proposed Order (11) |
| Jul 17, 2018 | 15 | Letter to Chief Judge Stark from Maryellen Noreika enclosing order (1) |
| Jul 17, 2018 | 15 | Main Document (11) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Attachments: # (1) Letter to Chief Judge Stark from Maryellen Noreika enclosing order)(Noreika, Maryellen) |
| Jul 10, 2018 | N/A | SO ORDERED (0) |
| Jul 9, 2018 | 13 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint proposed scheduling order to July 17, 2018 - filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (Noreika, Maryellen) |
| Jun 26, 2018 | N/A | Order (0) |
| Jun 25, 2018 | 11 | Answer to Counterclaim (8) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC.(Noreika, Maryellen) |
| Jun 8, 2018 | N/A | SO ORDERED (0) |
| Jun 6, 2018 | 8 | Answer to Complaint (9) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 6, 2018 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Jun 6, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Michael E. Joffre, and Deirdre M. Wells - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Apr 25, 2018 | N/A | SO ORDERED (0) |
| Apr 24, 2018 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to June 6, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Apr 18, 2018 | N/A | Case Assigned/Reassigned (0) |
| Apr 16, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Mist Acquisition, LLC, IBSA Institut Biochimique, S.A., Altergon, S.A., Mist Pharmaceuticals, LLC. Teva Pharmaceuticals USA, Inc. served on 4/16/2018, answer due 5/7/2018. (Blumenfeld, Jack) |
| Apr 13, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 4/13/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Apr 13, 2018 | 1 | Complaint (7) |
| Apr 13, 2018 | 1 | Exhibit A-B (39) |
| Apr 13, 2018 | 1 | Civil Cover Sheet (1) |
| Apr 13, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Apr 13, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/28/2018. Date of Expiration of Patent: 3/14/2024.Thirty Month Stay Deadline: 8/28/2020. (nmg) |
| Apr 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,691,411 B2; 7,723,390 B2. (nmg) |
| Apr 13, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mist Partners, LLC for Mist Acquisition, LLC; Corporate Parent IBSA Holding SA for IBSA Institut Biochimique, S.A. and No Parents or Affiliates Listed for Altergon SA and Mist Pharmaceuticals, LLC filed by filed by Altergon, S.A., IBSA Institut Biochimique, S.A., Mist Acquisition, LLC, Mist Pharmaceuticals, LLC. (nmg) |
| Apr 13, 2018 | 1 | Main Document (7) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2361078.) - filed by Mist Acquisition, LLC, IBSA Institut Biochimique, S.A., Altergon, S.A., Mist Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(nmg) |
